Fox Chase Cancer Center News

Fox Chase Researchers Find Novel Histone-Dependent PARP-1 Inhibitors More Effective at Treating Prostate and Renal Cancers

PHILADELPHIA (August 31, 2020)—In a recent study, researchers at Fox Chase Cancer Center identified agents that can specifically target the histone-dependent route of PARP-1 activation. This novel approach appears to be able to target cancer cells better than traditional NAD-like PARP-1 inhibitors and could have potential for developing new treatments for urologic tumors.

VIEW STORY

Fox Chase to Participate in Virtual Philadelphia Walk to End Colon Cancer

PHILADELPHIA (August 27, 2020) - Fox Chase Cancer Center proudly supports the Philadelphia Walk to End Colon Cancer, a fundraising event organized by the Colorectal Cancer Alliance (Alliance) to raise money for colorectal cancer research, education, and awareness. In accordance with COVID-19 social distancing guidelines, the yearly walk will be held virtually on Saturday, September 12.

VIEW STORY

Fox Chases Research Shows Text Messages Can Help New Mothers to Avoid Smoking

PHILADELPHIA (August 27, 2020) – Researchers at Fox Chase Cancer Center have published a study about preventing cigarette smoking relapse in urban, underserved women after they have given birth. Although much research has been conducted on smoking cessation in general, programs are not designed to help underserved mothers quit the habit long term.

VIEW STORY

Fox Chase Cancer Center Welcomes Christopher M.K.L. Yao

PHILADELPHIA (August 17, 2020) – Fox Chase Cancer Center announces the hiring of Christopher M.K.L. Yao, MD, FRCSC, who will join the Department of Surgical Oncology as an assistant professor in the academic clinician track in the Division of Head and Neck Surgery.

VIEW STORY